These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E. Laight DW; Desai KM; Gopaul NK; Anggård EE; Carrier MJ Eur J Pharmacol; 1999 Jul; 377(1):89-92. PubMed ID: 10448931 [TBL] [Abstract][Full Text] [Related]
4. Relationship between beta-endorphin/beta-lipotropin, hyperglycemia, and hyperinsulinemia in obese male Zucker rats. Elias AN; Vaziri ND; Pandian MR; Ansari MA Proc Soc Exp Biol Med; 1989 Nov; 192(2):157-60. PubMed ID: 2530589 [TBL] [Abstract][Full Text] [Related]
5. Influence of phytostanol phosphoryl ascorbate (FM-VP4) on insulin resistance, hyperglycemia, plasma lipid levels, and gastrointestinal absorption of exogenous cholesterol in Zucker (fa/fa) fatty and lean rats. Wasan KM; Zamfir C; Pritchard PH; Pederson RA J Pharm Sci; 2003 Feb; 92(2):281-8. PubMed ID: 12532378 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of peroxisome proliferator activator receptor-alpha and gamma ligands on intimal hyperplasia after balloon catheter-induced vascular injury in Zucker rats. Desouza CV; Murthy SN; Diez J; Dunne B; Matta AS; Fonseca VA; McNamara DB J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):297-305. PubMed ID: 14740079 [TBL] [Abstract][Full Text] [Related]
7. A low protein diet lowers islet insulin secretion but does not alter hyperinsulinemia in obese Zucker (fa/fa) rats. Tse EO; Gregoire FM; Magrum LJ; Johnson PR; Stern JS J Nutr; 1995 Jul; 125(7):1923-9. PubMed ID: 7616309 [TBL] [Abstract][Full Text] [Related]
8. Lipoprotein alterations in 10- and 20-week-old Zucker diabetic fatty rats: hyperinsulinemic versus insulinopenic hyperglycemia. Sparks JD; Phung TL; Bolognino M; Cianci J; Khurana R; Peterson RG; Sowden MP; Corsetti JP; Sparks CE Metabolism; 1998 Nov; 47(11):1315-24. PubMed ID: 9826206 [TBL] [Abstract][Full Text] [Related]
9. Appropriate Insulin Level in Selecting Fortified Diet-Fed, Streptozotocin-Treated Rat Model of Type 2 Diabetes for Anti-Diabetic Studies. Okoduwa SI; Umar IA; James DB; Inuwa HM PLoS One; 2017; 12(1):e0170971. PubMed ID: 28129400 [TBL] [Abstract][Full Text] [Related]
10. Leptin and its relation to obesity and insulin in the SHR/N-corpulent rat, a model of type II diabetes mellitus. Velasque MT; Bhathena SJ; Hansen CT Int J Exp Diabetes Res; 2001; 2(3):217-23. PubMed ID: 12369710 [TBL] [Abstract][Full Text] [Related]
11. Contribution of hyperinsulinemia to modulation of lipoprotein lipase activity in the obese Zucker rat. Boivin A; Deshaies Y Metabolism; 2000 Jan; 49(1):134-40. PubMed ID: 10647077 [TBL] [Abstract][Full Text] [Related]
12. Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment. Kudolo GB; Bressler P; DeFronzo RA J Lipid Mediat Cell Signal; 1997 Nov; 17(2):97-113. PubMed ID: 9459136 [TBL] [Abstract][Full Text] [Related]
13. Dynamics of insulin sensitivity, -cell function, and -cell mass during the development of diabetes in fa/fa rats. Topp BG; Atkinson LL; Finegood DT Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1730-5. PubMed ID: 17895283 [TBL] [Abstract][Full Text] [Related]
14. Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia. Sugimoto K; Rashid IB; Kojima K; Shoji M; Tanabe J; Tamasawa N; Suda T; Yasujima M Diabetes Metab Res Rev; 2008; 24(8):642-50. PubMed ID: 18973207 [TBL] [Abstract][Full Text] [Related]
15. Dietary fish protein hydrolysates containing bioactive motifs affect serum and adipose tissue fatty acid compositions, serum lipids, postprandial glucose regulation and growth in obese Zucker fa/fa rats. Drotningsvik A; Mjøs SA; Pampanin DM; Slizyte R; Carvajal A; Remman T; Høgøy I; Gudbrandsen OA Br J Nutr; 2016 Oct; 116(8):1336-1345. PubMed ID: 27751188 [TBL] [Abstract][Full Text] [Related]
16. The biomimetic [Cr(3)O(O(2)CCH(2)CH(3))(6)(H(2)O)(3)](+ )decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats. Sun Y; Clodfelder BJ; Shute AA; Irvin T; Vincent JB J Biol Inorg Chem; 2002 Sep; 7(7-8):852-62. PubMed ID: 12203022 [TBL] [Abstract][Full Text] [Related]
17. Effect of lipectomy on growth and development of hyperinsulinemia and hyperlipidemia in the Zucker rat. Liszka TG; Dellon AL; Im M; Angel MF; Plotnick L Plast Reconstr Surg; 1998 Sep; 102(4):1122-7. PubMed ID: 9734431 [TBL] [Abstract][Full Text] [Related]
18. Atherogenesis in two strains of obese rats. The fatty Zucker and LA/N-corpulent. Amy RM; Dolphin PJ; Pederson RA; Russell JC Atherosclerosis; 1988 Feb; 69(2-3):199-209. PubMed ID: 3348841 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative. Shibata T; Matsui K; Nagao K; Shinkai H; Yonemori F; Wakitani K Eur J Pharmacol; 1999 Jan; 364(2-3):211-9. PubMed ID: 9932726 [TBL] [Abstract][Full Text] [Related]
20. Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus. Park SH; Marso SP; Zhou Z; Foroudi F; Topol EJ; Lincoff AM Circulation; 2001 Aug; 104(7):815-9. PubMed ID: 11502708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]